NCT06760494View on ClinicalTrials.gov

Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With Explainability

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

May 30, 2024

Conditions
HCC - Hepatocellular CarcinomaMicrovascular Invasion (MVI)
Interventions
DIAGNOSTIC_TEST

the MAPUSE model

Using the MAPUSE model to predict MVI status before surgical resection for HCC patients

Trial Locations (2)

100853

Chinese PLA General Hospital, Beijing

510080

the First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Chinese PLA General Hospital

OTHER

NCT06760494 - Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With Explainability | Biotech Hunter | Biotech Hunter